Production (Stage)
iSpecimen Inc.
ISPC
$1.14
$0.021.79%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.06M | 9.29M | 10.39M | 10.51M | 9.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.06M | 9.29M | 10.39M | 10.51M | 9.27M |
| Cost of Revenue | 4.96M | 5.30M | 5.41M | 5.24M | 4.67M |
| Gross Profit | 3.10M | 3.99M | 4.99M | 5.26M | 4.59M |
| SG&A Expenses | 11.30M | 13.19M | 11.20M | 11.80M | 12.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.42M | 22.02M | 20.15M | 20.75M | 20.90M |
| Operating Income | -11.37M | -12.73M | -9.76M | -10.25M | -11.63M |
| Income Before Tax | -11.25M | -12.50M | -9.52M | -10.20M | -11.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.25 | -12.50 | -9.52 | -10.20 | -11.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.25M | -12.50M | -9.52M | -10.20M | -11.57M |
| EBIT | -11.37M | -12.73M | -9.76M | -10.25M | -11.63M |
| EBITDA | -11.11M | -12.47M | -9.50M | -10.03M | -11.44M |
| EPS Basic | -11.87 | -17.52 | -18.94 | -21.50 | -25.50 |
| Normalized Basic EPS | -7.42 | -10.95 | -11.84 | -13.44 | -15.94 |
| EPS Diluted | -11.87 | -17.52 | -18.94 | -21.50 | -25.50 |
| Normalized Diluted EPS | -7.42 | -10.95 | -11.84 | -13.44 | -15.94 |
| Average Basic Shares Outstanding | 4.71M | 2.84M | 2.16M | 1.93M | 1.82M |
| Average Diluted Shares Outstanding | 4.71M | 2.84M | 2.16M | 1.93M | 1.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |